Trademark: 87425888
Word
SALUBRISBIO
Status
Registered
Status Code
700
Status Date
Tuesday, May 14, 2019
Serial Number
87425888
Registration Number
5748146
Registration Date
Tuesday, May 14, 2019
Mark Type
5
Filing Date
Wednesday, April 26, 2017
Published for Opposition
Tuesday, February 26, 2019

Trademark Owner History

Classifications
5 Pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicines for human purpose, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biological preparations for medical purposes, namely, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biochemical medicines, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Drugs for medical purposes in the nature of medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Injections, namely, vaccines and injectable medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of components of finished pharmaceutical preparations, which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Dietetic substances adapted for medical use, namely, dietetic beverages and food for medical purposes, the foregoing dietetic food and beverages containing vitamin, protein, minerals, lecithin, glucose, amino acid, folic acid, fruit juice, fruit oil, honey, seaweed glue, fish oil, cod-liver oil, cubilose, restoratives, plant fibre, nutrition powder, nutrient capsule, nutrient tablets, and containing mineral food-supplements, the foregoing dietetic foods and beverages are used for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases
The mark consists of stylized word of "SalubrisBio".
Color is not claimed as a feature of the mark.

Trademark Events
Jul 27, 2017
Examiners Amendment -Written
Apr 29, 2017
New Application Entered
May 3, 2017
New Application Office Supplied Data Entered
Jul 24, 2017
Assigned To Examiner
Jul 27, 2017
Examiners Amendment E-Mailed
Jul 27, 2017
Notification Of Examiners Amendment E-Mailed
Jul 27, 2017
Examiner's Amendment Entered
Jul 27, 2017
Approved For Pub - Principal Register
Aug 30, 2017
Notification Of Notice Of Publication E-Mailed
Sep 19, 2017
Published For Opposition
Sep 19, 2017
Official Gazette Publication Confirmation E-Mailed
Nov 14, 2017
Noa E-Mailed - Sou Required From Applicant
May 14, 2018
Sou Extension 1 Filed
Jun 18, 2018
Abandonment - No Use Statement Filed
Jun 18, 2018
Abandonment Notice Mailed - No Use Statement Filed
Jul 17, 2018
Teas Petition To Revive Received
Jul 17, 2018
Petition To Revive-Granted
Jul 17, 2018
Sou Extension Received With Teas Petition
Jul 18, 2018
Notice Of Revival - E-Mailed
Sep 6, 2018
Case Assigned To Intent To Use Paralegal
Sep 21, 2018
Sou Extension 1 Granted
Sep 22, 2018
Notice Of Approval Of Extension Request E-Mailed
Oct 5, 2018
Assigned To Petition Staff
Sep 24, 2018
Teas Petition To Amend Basis Received
Oct 9, 2018
Petition To Director - Change Basis - Granted
Nov 14, 2018
Notice Of Allowance Cancelled
Dec 17, 2018
Abandonment - No Use Statement Filed
Dec 17, 2018
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 22, 2019
Case Assigned To Intent To Use Paralegal
Jan 22, 2019
Reinstatement Granted - Inadvertently Abandoned
Jan 23, 2019
1(B) Basis Deleted; New Basis Requested
Jan 25, 2019
Notice Of Reinstatement Mailed
Feb 6, 2019
Notification Of Notice Of Publication E-Mailed
Feb 26, 2019
Published For Opposition
Feb 26, 2019
Official Gazette Publication Confirmation E-Mailed
May 14, 2019
Registered-Principal Register
May 14, 2024
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24